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Telomeres are repetitive DNA structures that, together
with the shelterin and the CST complex, protect the ends
of chromosomes. Telomere shortening is mitigated in stem
and cancer cells through the de novo addition of telomeric
repeats by telomerase. Telomere elongation requires the
delivery of the telomerase complex to telomeres through a
not yet fully understood mechanism. Factors promoting
telomerase–telomere interaction are expected to directly
bind telomeres and physically interact with the telomerase
complex. In search for such a factor we carried out a
SILAC-based DNA–protein interaction screen and identi-
fied HMBOX1, hereafter referred to as homeobox telomere-
binding protein 1 (HOT1). HOT1 directly and specifically
binds double-stranded telomere repeats, with the in vivo
association correlating with binding to actively processed
telomeres. Depletion and overexpression experiments
classify HOT1 as a positive regulator of telomere length.
Furthermore, immunoprecipitation and cell fractionation
analyses show that HOT1 associates with the active telo-
merase complex and promotes chromatin association of
telomerase. Collectively, these findings suggest that HOT1
supports telomerase-dependent telomere elongation.
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Introduction
Telomeres, the nucleoprotein structures at the ends of
chromosomes, consist of 50-TTAGGG-30 repeats bound by a
dedicated set of proteins forming the shelterin complex (Palm
and de Lange, 2008). Three members of the six protein complex
directly bind telomeric DNA and were the only direct telomere-
specific binding proteins known so far: TRF1 and TRF2 bind
double-stranded DNA (dsDNA; Zhong et al, 1992; Bilaud et al,
1997; Broccoli et al, 1997), whereas POT1 binds single-stranded
50-TTAGGG-30 repeats (Baumann, 2001). This complex
constitutively associates with telomeres and shields the ends
of linear chromosomes from being recognized as a double-
stranded break, thus protecting telomeres from end-to-end
fusions (Palm and de Lange, 2008). While this solves the
end-protection problem (de Lange, 2009), maintaining
telomere integrity itself is of outstanding importance and
major factors may have remained elusive.
Telomere length homeostasis, a crucial process in stem cell
biology, aging and cancer, depends on the equilibrium
between telomere lengthening (in most cases due to telomer-
ase activity) and shortening reactions (generally due to
replication and controlled processing) (Jain and Cooper,
2010). Telomerase is capable of adding telomeric repeats to
chromosome ends de novo. The enzyme works as a
ribonucleoprotein complex, which consists of a catalytic
subunit with reverse-transcriptase activity (called TERT),
and an RNA serving as the elongation matrix for telomeres
(called TR or TERC) (Greider and Blackburn, 1989). While
these two core elements are sufficient for telomerase activity
in vitro, biochemical analyses have shown that in vivo
telomerase resides in a large complex of about 1 MDa
(Schnapp et al, 1998). Some additional components of this
large multi-subunit holoenzyme complex have been
identified. In particular, the core components of box H/ACA
small nucleolar ribonucleoprotein particles (snoRNPs), DKC1
(dyskerin), GAR1, NHP2 and NOP10, are part of the active
telomerase complex, and are necessary for proper RNP
assembly as well as for TERC stability (Mitchell et al, 1999;
Wang and Meier, 2004). More recently, the ATPases RUVBL1
and RUVBL2 have been identified as factors essential for
holoenzyme assembly (Venteicher et al, 2008), and TCAB1
(WDR79/WRAP53), identified as a DKC1 interaction partner,
was shown to be required for proper localization of CAB box
containing small Cajal body (CB)-specific RNPs (scaRNPs) to
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CBs, including TERC, and is part of the active telomerase
complex (Tycowski et al, 2009; Venteicher et al, 2009).
The presence of major scaRNA processing and trafficking
factors in the telomerase complex hints to an important
aspect of telomerase cell biology: the orchestrated maturation
of telomerase and interaction with telomeres in the CB.
Telomere maintenance by telomerase requires that both
TERT and TERC are recruited from distinct subnuclear sites
to telomeres during S phase (synthesis phase) (Tomlinson
et al, 2008). Like other scaRNAs, TERC contains a common
CB-specific localization signal and accumulates in CBs (Ja´dy
et al, 2004; Zhu et al, 2004), where it is found together with
TERT (Tomlinson et al, 2008). In a cell cycle-dependent
manner, telomerase-containing CBs are then recruited to
telomeres, suggesting that CBs represent an enzymatic hub
in which telomere elongation by telomerase takes place (Ja´dy
et al, 2006; Tomlinson et al, 2006; Cristofari et al, 2007). This
trafficking model is further supported by telomere elongation
defects in the absence of TCAB1 or presence of dysfunctional
TCAB1, disrupting TERC accumulation in the CB (Venteicher
et al, 2009; Zhong et al, 2011). Nevertheless, so far it remains
elusive how telomeres are recruited to CBs, how this selective
interaction is regulated and what drives the conversion from
telomeres in a closed state, in which telomerase has little or
no access, to telomeres in an open, accessible state.
Telomerase is usually limiting and, under physiological con-
ditions, acts preferentially on short telomeres (Hemann et al,
2001; Britt-Compton et al, 2009), due to a well-established
negative feedback loop mediated in cis by TRF1 and POT1,
likely by hiding the 30-overhang, which serves as a template for
telomerase (Loayza and de Lange, 2003). Indeed, diminished
loading of POT1 or expression of a dominant-negative version
lacking DNA-binding activity leads to telomere elongation by
telomerase, and in vitro experiments have shown that POT1 is
competing with telomerase for its substrate (Loayza and de
Lange, 2003; Ye et al, 2004; Kelleher et al, 2005; Lei et al, 2005).
However, POT1 also interacts with TPP1, and both proteins
together promote telomerase activity in vitro (Latrick and Cech,
2010). Furthermore, TPP1 has been shown to be required for
the recruitment of telomerase to its substrate in vitro and to
telomeric chromatin in vivo (Xin et al, 2007; Abreu et al, 2010;
Tejera et al, 2010; Zaug et al, 2010; Zhong et al, 2012). While
TPP1 has been proposed as a telomerase recruiter, it does not
completely fit the definition, since it has initially been
described as a negative regulator of telomere length in
telomerase-positive cells (Liu et al, 2004; Ye et al, 2004),
although these results may in part be attributed to secondary
effects, such as the lack of POT1 tethering to telomeres in the
absence of TPP1. Based on these bivalent results, a ying-yang
model for telomerase recruitment and activity control has been
proposed for TPP1–POT1 (Xin et al, 2007). Indeed, recently, a
specific patch of amino acids on the surface of TPP1, the TEL
patch (TPP1 glutamate (E)- and leucine (L)-rich patch), has
been identified as crucial for the TPP1 function in telomerase
recruitment and regulation (Nandakumar et al, 2012). Analysis
of point mutations within the TEL patch demonstrated that the
TEL patch is physically and functionally distant from the
portion of TPP1 engaged in end protection, separating these
two functions (Nandakumar et al, 2012).
Regulating the amount of telomeric repeats added by
telomerase also involves how long telomerase can act on a
given chromosome end. Therefore, turning off telomerase
needs to be regulated in addition to the recruitment step and
processivity control. In a recent study, Chen et al (2012)
described the human CST (CTC1, STN1 and TEN1) complex
as a terminator of telomerase activity (Chen et al, 2012). CST
competes with POT1–TPP1 for telomeric DNA and is increas-
ingly enriched on telomeric DNA during late S/G2 phase,
correlating with the period in the cell cycle when telomerase
action is terminated. In agreement with a suppression of
telomerase action, depletion of any of the three CST complex
members led to a steady increase in telomere length in a
telomerase-dependent manner. The authors suggested that CST
binds to telomerase-extended 30-ends and thereby suppresses
telomerase access and further elongation (Chen et al, 2012).
However, depletion of STN1 has been reported not to affect
telomere length in various telomerase-positive cellular contexts
(Wang et al, 2012) and murine CTC1-null cells do not exhibit
the reported telomere lengthening phenotype (Gu et al, 2012).
The proposed model is nonetheless appealing, as human CST
subunits stimulate DNA polymerase a-primase (Casteel et al,
2009) and therefore CST binding to telomerase-extended
30-ends could initiate a switch from telomere elongation to
fill-in synthesis. This mechanism could provide an autonomous
end point to telomerase action at single telomeres, ensuring
that every telomere is extended by telomerase once and only
once during every cell cycle (Chen et al, 2012).
We reasoned that the identification of novel telomere-
binding proteins would be a first step to the identification
of additional factors implicated in telomere biology. SILAC-
based quantitative mass spectrometry (MS) has been adapted
for DNA–protein interactions (Mittler et al, 2009) and has been
used by us and others successfully to identify factors binding to
particular functional DNA fragments (Markljung et al, 2009;
Butter et al, 2010; Bartels et al, 2011; Butter et al, 2012). For our
purpose, we applied this approach to telomeric DNA in order
to screen for telomere repeat-binding proteins and identified
the protein HOT1 (HMBOX1; homeobox telomere-binding
protein 1). HOT1 had previously been described as a putative
transcriptional repressor based on reporter gene assays (Chen
et al, 2006) and had been identified as a telomere-associated
protein by the proteomics of isolated chromatin segments
(PICh) approach (De´jardin and Kingston, 2009). Here we
demonstrate that HOT1 directly binds to telomeric DNA, and
characterize this binding in atomic detail by resolving a crystal
structure of the HOT1 homeobox domain in a cocrystal with
telomeric DNA. In vivo, HOT1 localizes to a subset of telomeres
with a higher degree of HOT1–telomere association in cellular
contexts of elevated telomere processing. In addition, we show
that HOT1 associates with the active telomerase complex and
that HOT1 is required for telomerase chromatin binding. These
findings suggest that HOT1 contributes to the association of
telomerase with telomeres and telomere length maintenance in
various cellular settings, and classify HOT1 as the first direct
telomere-binding protein that acts as a positive regulator of
telomere length.
Results
Identification of HOT1 as a direct telomere repeat-
binding protein
To identify telomere-binding proteins we used polymerized
biotinylated double-stranded oligonucleotides of the telo-
meric sequence (50-TTAGGG-30) and a scrambled control
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sequence (50-GTGAGT-30), separately immobilized on para-
magnetic streptavidin beads and incubated with heavy and
light SILAC-labelled nuclear extracts from HeLa cells, respec-
tively. Specific binding of proteins is detected by incubation
of cell lysates encoded by ‘heavy’ amino acids (15N- and
13C-labelled Lys and Arg) with the bait sequence, while a
control sequence is incubated with ‘light’, nonlabelled amino
acids. Specific binders display a differential SILAC ratio,
whereas background binders have a 1:1 ratio. After mild
washing, bead fractions were combined and captured pro-
teins were analysed by quantitative, high-resolution MS (Cox
and Mann, 2008) (Figure 1A).
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Figure 1 Detection of specific telomere-interacting proteins. (A) A schematic of the quantitative SILAC-based DNA interaction screen with
DNA oligonucleotides containing either the telomeric repeat or a control sequence. Specific interaction partners are differentiated from
background binders by a SILAC ratio other than 1:1. (B) MS spectra of representative peptides from the ‘forward’ pull-down experiment. The
heavy peptide partners are easily detected (red dots), while the light partner is barely observable (blue dots) in the mass spectrum. (C) Two-
dimensional interaction plot: known shelterin components cluster together with HOT1, demonstrating enrichment at the telomere sequence
compared to the control sequence. (D) Summary of the MS data for HOT1 and the core shelterin components from the SILAC-based
DNA–protein interaction screens carried out with nuclear extracts derived from HeLa and murine ES cells.
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We identified all the six core shelterin components with a
SILAC ratio of about 10 or higher in the ‘forward’ and about
0.1 in the ‘reverse’ experiment, in which we had switched the
labels (Figure 1B–D, Supplementary Figure S1 and Supple-
mentary Table S1). In contrast, none of the proteins known to
interact with shelterin were identified with SILAC ratios
sufficiently high to be consistent with telomere binding,
demonstrating that this approach was very stringent and
exclusively detected telomere repeat-binding proteins and
their strong interaction partners (Figure 1C). In addition to
the shelterin components, we found the protein HOT1 with a
high SILAC ratio that clustered with those of the shelterin
components (Figure 1B–D, Supplementary Figure S1 and
Supplementary Table S1). This indicates that HOT1 must
either strongly associate with the shelterin complex or
directly bind to the 50-TTAGGG-30 repeats.
To verify that the HOT1 identification was not cancer-,
cell- or species-specific, we repeated our telomere-binding
assay with SILAC-labelled nuclear extracts derived from
mouse embryonic stem cells (ES cells). Again, all compo-
nents of the shelterin complex and HOT1 were identified with
SILAC ratios, indicating specific binding to the telomere
repeats (Figure 1D and Supplementary Table S2). Here we
also identified the two paralogues, POT1a and POT1b, which
result from a gene duplication of the Pot1 gene in the rodent
lineage (Hockemeyer et al, 2006), underscoring the specificity
of our assay for direct telomere-binding proteins. Hence,
HOT1 is a putative telomere repeat-binding protein
conserved in mammalian cells.
HOT1 contains a homeobox domain (Chen et al, 2006),
suggesting that it may bind DNA directly. To determine
whether HOT1 was detected in our assay due to direct
binding to the 50-TTAGGG-30 repeats, we performed DNA-
binding assays with HOT1 in vitro. Recombinant HOT1 bound
specifically to telomeric repeats, whereas no binding to the
negative control repeat fragments (50-GTGAGT-30) was
detected (Figure 2A). Exhibiting similar binding behaviour
as TRF1, HOT1 was not enriched on any of the subtelomeric
variant repeats 50-TCAGGG-30, 50-TGAGGG-30 and 50-TTG
GGG-30, nor on the C. elegans telomere 50-TTAGGC-30 repeat
sequence (Wicky et al, 1996; Figure 2A). To test whether
HOT1 also associates with telomeres in vivo, we performed
chromatin immunoprecipitation (ChIP) experiments with ex-
tracts from HeLa cells using an antibody directed against
HOT1. Similar to TRF2, HOT1 IPs showed enrichment of
telomeric DNA in comparison to two negative controls
(anti-GFP antibody and IgG; Figure 2B). Thus, HOT1 is a
direct and specific telomere repeat-binding protein.
HOT1 recognizes telomeric DNA by means of its
homeodomain
Driven by these findings and with the aim to fully understand
the molecular interactions between HOT1 and telomeric DNA,
we crystallized the DNA-binding domain (DBD) of HOT1 with
telomeric DNA. In order to identify a construct suitable for
crystallization, we initially tested six different HOT1 fragments
for their DNA-binding ability (Supplementary Figure S2).
The three longer constructs Q144–A345, L156–A345 and
G233–A345 all bound to immobilized telomeric dsDNA baits,
demonstrating that the homeodomain of HOT1 is sufficient for
recognizing telomeric DNA and that integrity of the predicted
N-terminal POU-specific (POUs) domain (Chi et al, 2002) is not
required. The three shorter constructs (P242–A345, P254–A345
and R271–A345) were not able to bind to the bait DNA
(Supplementary Figure S2). For crystallization, we reconstituted
and purified telomeric DNA complexes with all three binding
constructs, but only one (G233–A345) yielded crystals when
reconstituted with a duplex telomeric DNA (50-cTGTTAGGGTTA
GGGTTAG-30 and 30-ACAATCCCAATCCCAATCt-50) similar to the
one present in the crystal structures of the TRF1 and TRF2
homeodomains bound to telomeric DNA (Court et al, 2005).
The optimized crystals diffracted to 2.9 A˚ resolution and
we could solve the structure by molecular replacement using
the NMR model of the human HOT1 homeodomain (residues
268–343, PDB entry 2CUF, unpublished data from RIKEN
Structural Genomics/Proteomics Initiative). In the orthor-
hombic crystals, the DNA forms an infinite double helix via
a C–T nonWatson–Crick base pairing of the single-base
overhangs (not shown). Two copies of the HOT1 DBD are
bound to one duplex DNA that comprises two and a half
50-TTAGGG-30 repeats in a regular and undistorted B-form
conformation (Supplementary Figure S3). As expected, and
in accordance with the NMR model, the homeodomain of
HOT1 folds into a small structure of three consecutive helices,
a1 (res. 276–288), a2 (res. 293–309) and a3 (res. 322–342),
separated by a loop (a1–a2) and a turn (a2–a3; Figures 2C
and 3A, and Supplementary Figure S3). The N-terminal
residues 233–266 and the two C-terminal residues were not
defined by electron density and were, thus, not built.
As reported for TRF1 and TRF2, each copy of the HOT1
homeodomain binds to the major groove of the DNA double
helix around a 50-TTAGGG-30 motif (Figure 2C and
Supplementary Figure S3). Typical for homeobox domains,
binding to DNA is mainly mediated by an N-terminal
unstructured arm (267–276), the loop between a1 and a2,
and the C-terminal a3 (Figure 2C). Binding and sequence
recognition is achieved through a combination of either
Figure 2 The DBD of human HOT1 recognizes telomeric DNA in a sequence-specific manner. (A) Sequence-specific pull-down of recombinant
HOT1, TRF1 (positive control) and TBP (TATA-binding protein, negative control). Proteins were incubated with dsDNA of telomeric repeats
(50-TTAGGG-30), the control sequence (50-GTGAGT-30), the subtelomeric repeat variants (50-TCAGGG-30, 50-TGAGGG-30 and 50-TTGGGG-30, as
well as the C. elegans telomere repeat 50-TTAGGC-30). All DNA substrates were concatemerized from 60 bp oligonucleotides to larger DNA
fragments (on average at least 1 kb). (B) ChIP of telomeric DNA using antibodies against HOT1, TRF2 (positive control), GFP and IgG (negative
controls). Representative slotblot images are shown for ChIP from HeLa extracts after hybridization with a telomeric and genomic control.
Input dilutions demonstrate the linearity of the signals acquired. (C) Structure of the DBD of HOT1 bound to double-stranded telomeric DNA.
The protein is shown as a cartoon representation (orange), whereas DNA is shown as a stick model (grey). The interacting amino acid residues
in HOT1 are shown as blue sticks, water molecules as red spheres and protein–DNA contacts are visualized as green dashed lines.
(D) Schematic representation of all protein–DNA contacts in the complex. (E) Sequence-specific pull-down of FLAG–HOT1 and selected
single mutations to investigate binding specificity. Proteins were incubated with either telomeric repeats (50-TTAGGG-30) or a control
oligonucleotide (50-GTGAGT-30). (F) Atomic details of DNA sequence recognition by HOT1. K335 of helix 3 is involved in direct hydrogen
bonding to O6 of G8 and O6 of G9. N332 of helix 3 specifically recognizes A110 of the complementary strand by forming two direct H-bonds
with the bicyclic ring system of A110 (N6 and N7) (left panel). R271 of the N-terminal arm binds two bases of an AT base pair, directly to T90 and
via a water-mediated H-bond to A12 (right panel). Source data for this figure is available on the online supplementary information page.
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water-mediated or direct contacts with the phosphate back-
bone (on both sides of the major groove) and the DNA
nucleobases in the major (a3) and minor groove (N-terminal
arm; Figures 2C and D; the structure is deposited under PBD
entry 4J19; for crystallographic statistics please see Table I).
Lysine 335 is a key residue for telomere sequence
specificity of HOT1
In order to bind a specific sequence, the HOT1 homeo-
domain must recognize and directly contact individual
bases of telomeric DNA. We could identify five such
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direct interactions (R271, Y327, N332, K335, R339;
Figures 2C, D and F) in our structure. Four of these residues
reside on helix 3, which is generally referred to as the
recognition helix and one, R271, is part of the unstructured
N-terminal arm.
In detail, Y327 binds to N6 of the adenine base of A6 via a
water molecule (Figure 2F). K338 and R339 are in close
proximity and oriented towards the phosphate of G8 and the
nucleobase of G7, respectively, but their electron density
was not as clearly defined, probably due to conformational
flexibility. However, in our mutant analysis the single mutants
K338A and R339A no longer bind DNA, and Y327A shows
weakened binding—a clear indication that these residues are
important for binding (Figure 2E). In addition, N332 makes
two direct hydrogen bonds with the adenine base of A110 of
the complementary strand, but mutating N332 to A had no or
little effect in our binding assay.
The interaction of a lysine, K335, of this helix might be the
most noteworthy. The e-amino group of K335 makes a
bifurcated hydrogen bond with carbonyl oxygens of two
adjacent guanine bases (G8 and G9) in the major groove.
Mutation of this lysine to alanine (K335A) not only
completely abrogates binding of HOT1 to the 50-TTAGGG-30
motif, suggesting that this residue is essential for binding
(Figures 2E and F), but this mutation also results in the
‘gained’ ability to bind a nontelomeric control sequence
(50-GTGAGT-30) in our pull-down experiments. To our under-
standing, this ‘gain-of-function’ is a strong indication that
TRF1
HOT1
H3
H3
H1
H1
G7
G8
G9
H2
A
B
Figure 3 Comparison of the molecular recognition of telomeric DNA by HOT1 and TRFs. (A) Schematic representation of the domain structure
of the homeobox domains of TRF1, TRF2 and HOT1. Residues involved in DNA binding are marked with an asterisk (HOT1) or diamond
(TRF1). Strictly conserved residues are shown with white font on red background and conserved residues are written in red font. (B)
Superposition of structures of the HOT1 DBD and TRF1 DBD bound to telomeric DNA. Both binding domains recognize a different set of DNA
bases, resulting in a different positioning relative to the 50-TTAGGG-30 motif.
Table I Crystallographic statistics
Data collection
Data set Native
Beamline SLS PXII
Space group C2221
Unit cell parameters (A˚) a¼ 111.4, b¼ 116.5, c¼ 75.7
Wavelength (A˚) 1.00
Resolution range (A˚)a 46.2–2.9
Unique reflections 11126
Multiplicity 3.6 (3.6)
Completeness (%)a 98.9 (97.4)
I/s(I)a 18.8 (2.2)
Rmerge (%)
a 3.3 (45.6)
Refinement
Resolution range (A˚) 46.2–2.90
Rfree (%) 22.1
Rwork (%) 17.2
r.m.s.d. bond (A˚) 0.006
r.m.s.d. angle (deg) 1.0
B-factor 2 (A˚2) 79.5
Ramachandran validation
Favoured (%) 99.3
Allowed (%) 0.7
Outliers (%) 0
aValues in parentheses correspond to the highest resolution shell.
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K335 is a critical determinant for recognizing and binding to
the telomeric sequence and, thus, for the specificity of HOT1.
Cooperatively, residues in helix 3 recognize a 50-AGGGT-30
(¼A0) motif in the telomeric DNA. Furthermore, residues
K325, N328 and R334 of this helix bind to the ribose
phosphate backbone either directly (K325 to A110, and R334
to A6) or through water (N328 to A110 and C120). Apart from
helix 3, we observe sequence-specific interactions from
residues in the a1–a2 loop (Y291 binding to the phosphate
O of G7) and the N-terminal arm. In full-length HOT1, this
arm is predicted to be part of an unstructured stretch ofB65
residues between the homeodomain and the preceding puta-
tive POUs domain. Notably, in the structures of TRF1 and
TRF2 this arm was discussed to be important for extending
the DNA-binding interface by adding specificity and affinity
(Court et al, 2005). In our structure, the hydroxyl group of
S270 of this arm binds to the G14 backbone phosphate, and
R271 specifically contacts both base moieties of the A12–T90
base pair, either directly (T90), or through a water molecule
(A12; Figure 2F). The importance of R271 was also confirmed
by the fact that mutating this residue to alanine (R271A)
completely abolishes DNA binding (Figure 2E). As outlined in
Figure 2D, the homeodomain of HOT1 docks onto telomeric
DNA by specifically interacting with nucleobases and back-
bone groups of more than one telomeric repeat. In particular,
R271 binds to the A12–T90 base pair of the following repeat.
This overlapping binding, which was also seen in the struc-
tures of TRF1 and TRF2, accounts for the repetitive nature of
telomeric DNA and probably provides an extra level of
selectivity.
While TRF1 and TRF2 also recognize telomeric dsDNA via
their respective homeobox domains, they only share low
sequence similarity with the homeodomain of HOT1
(13 and 5%, respectively, Figure 3A) and DNA binding is
different in both cases. TRF1 and TRF2 both bind DNA via
highly conserved interactions, involving direct interactions of
a3 to TTxGG (direct contacts with phosphate (x) or bases),
or xAGGGTx when water-mediated contacts are included.
In HOT1, a3 of the homeodomain recognizes AxGGT directly
(or AxGGTxAx with all resolved contacts; Court et al, 2005).
When aligning and superimposing the DNA moieties of the
TRF1 and HOT1 crystal structures, the difference in binding is
easily visualized (Figure 3B). With respect to TRF1, HOT1 is
shifted ‘down’ (50-30) the major groove by about one base
and towards the subsequent telomeric repeat.
Our crystal structure reveals in atomic detail how HOT1
specifically recognizes and binds 50-TTAGGG-30 repeats by
means of its homeodomain. We could underpin these find-
ings with mutational analyses and DNA pull-down assays,
and we conclude that K335 is a key residue for telomere
recognition and binding in HOT1.
HOT1–telomere associations correlate with the degree
of telomere processing
To investigate the interaction between HOT1 and telomeres
in vivo, we analysed HOT1 intracellular localization by
immunoFISH (immunohistochemistry combined with fluores-
cence in situ hybridization) microscopy in HeLa cells. In
agreement with previous observations (De´jardin and
Kingston, 2009), HOT1 showed a nuclear-punctuated
localization pattern, but in contrast to TRF1 and TRF2 only
associated with a subset of telomeres. Colocalization between
HOT1 and telomeric DNA was observed in about 90% of all
cells, with on average 4.5 HOT1 and telomeric foci
colocalizing per cell (Figure 4A, Supplementary Figure S4a).
To study the HOT1 localization in another cell type, we
performed IF stainings in mouse ES cells (Figure 1D).
Interestingly, in this setting we observed a higher degree of
colocalization of HOT1 with telomeres, with an average of
13.5 HOT1 and TRF1 foci colocalizing (Figure 4B). In telo-
merase-positive cancer cells, such as HeLa, only a small
fraction of telomeres is actively processed, as telomerase is
only associated with a few telomeres at any given time (Ja´dy
et al, 2006; Tomlinson et al, 2006). Here most telomeres are
believed to exist in a ‘closed’ state, while only some telomeres
are in an ‘open’, actively processed state. In contrast, ES cells
have high telomerase activity and maintain long telomeres
(Varela et al, 2011). We reasoned that more colocalization
events of HOT1 with telomeres might reflect the degree of
active telomere extension in these cells. If this was true, then
cells that very actively extend their telomeres should have the
highest frequency of HOT1–telomere associations. To test this
hypothesis, we carried out IF stainings for HOT1 on pachytene
chromosome spreads from mouse spermatocytes, in which
telomerase very actively elongates telomeres (Eisenhauer
et al, 1997; Kozik et al, 1998; Yashima et al, 1998; Riou
et al, 2005; Tanemura et al, 2005), using SYCP3 as a marker
for the synaptonemal complex/the chromosome axis
(Adelfalk et al, 2009). In agreement with a correlation
between telomere processing and HOT1–telomere association,
HOT1 robustly localized to telomeres on all spreads analysed
with on average 87% of chromosome ends being HOT1
positive (Figure 4C). We also confirmed this frequent associa-
tion of HOT1 with telomeres in mouse testes sections using
the same IF set-up. Again, we could confirm the prominent
localization of HOT1 to telomeres in SYCP3-positive pachy-
tene cells, highlighting the in vivo relevance of our discovery
(Supplementary Figure S5). Together, this data validates the
in vivo localization of HOT1 to telomeres and suggests that
HOT1 is a dynamic telomere-binding protein, putatively
associated with actively processed telomeres.
HOT1 interacts with the active telomerase complex
and associates with CBs
To gain further insights about HOT1 function at telomeres, we
performed HOT1 immunoprecipitation assays combined with
quantitative MS (Vermeulen et al, 2008), using both a
polyclonal rabbit and a monoclonal mouse HOT1 antibody
and SILAC-labelled nuclear protein extracts from HeLa cells.
HOT1 itself was recovered with SILAC ratios indicative of
specific binding to the antibody (Figure 5A and Supplemen-
tary Figure S6a). We also identified several proteins relevant
to telomere homeostasis: the four core components of box
H/ACA snoRNPs (DKC1, GAR1, NHP2 and NOP10; all part of
the active telomerase RNP (Wang and Meier, 2004)) and the
Ku70–Ku80 heterodimer proteins. We validated several of
these interactions by co-IP experiments, confirming a physi-
cal interaction of endogenous HOT1 with components of
the active telomerase complex (Figure 5B, Supplementary
Figure S6 and Supplementary Tables S3–S6). In addition, CB
proteins, notably the CB-scaffolding and -marker protein
Coilin (Cioce and Lamond, 2005), were strongly enriched in
our IP experiments (Figures 5A, B, Supplementary Figure S6a
and Supplementary Tables S3–S6), indicating that HOT1
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functions in the CB, where telomerase is assembled and
potentially brought together with telomeres (Cioce and
Lamond, 2005; Ja´dy et al, 2006; Tomlinson et al, 2006), or
in association with CB components in the nucleoplasm. We
could further validate these interactions with analogous
immunoprecipitations using extracts from mouse ES cells
(Supplementary Figure S6b and Supplementary Table S7). It
is noteworthy that in none of our HOT1 IPs any of the
shelterin components were enriched and that in agreement
with this HOT1 was not identified in a reciprocal IP of the
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shelterin component POT1 (Supplementary Figure S6c and
Supplementary Table S8), suggesting that HOT1 does not
directly interact with the shelterin complex.
The interaction of HOT1 with the active telomerase com-
plex components box H/ACA snoRNPs subunits (Wang and
Meier, 2004) raises the possibility that HOT1 binds to
active telomerase. To substantiate this hypothesis, we
performed immunoprecipitation experiments followed by
telomerase activity measurements using the quantitative
TRAP (telomere repeat amplification protocol) assay for
immunoprecipitates obtained from IPs for both HOT1 and
the positive control DKC1. Indeed, we detected telomerase
activity in both cases (Figures 5C and 5D), while five other
nuclear DNA-binding proteins (TBP, YY1, STAT3,
Histone3[K4me3] and CENP-B) did not show any enrichment
of telomerase activity compared to an IgG control. Antibodies
against TRF1 and TRF2 immunoprecitated telomerase activ-
ity, putatively dependent on the previously established link
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corners. Scale bars represent 5mm. The quantification of the frequency of colocalization events was done after a 3D reconstruction of the
acquired Z-stacks (n¼ 179). The average value is indicated by a red bar. Source data for this figure is available on the online supplementary
information page.
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between the shelterin component TPP1 and telomerase (Xin
et al, 2007). In sum, we conclude that HOT1 associates with
the active telomerase complex.
To corroborate the physical interaction between HOT1 and
Coilin, we performed IF stainings for HOT1 and Coilin in
nonsynchronized HeLa cells. After deconvolution and 3D
reconstruction of the IF images the colocalization between
both proteins was analysed. In about 85% of all cells ana-
lysed, we observed colocalization of one to seven HOT1 foci
with CBs (Figure 5E). Remarkably, HOT1 foci preferentially
localized to the periphery of Coilin, reminiscent of previous
findings on the association of telomerase RNA and telomeres
with CBs (Ja´dy et al, 2006). This data underscores the idea
that HOT1 might be associated with actively processed
telomeres in a telomerase-positive context.
HOT1 is a positive regulator of telomere length
The differential degree of the HOT1–telomere colocalization,
and the association with the active telomerase complex as
well as the reminiscent localization to the periphery of CBs,
suggested that HOT1 might be involved in telomere main-
tenance. To investigate this, we depleted both HOT1 and
TCAB1 in HeLa cells with endoribonuclease-prepared siRNA
(esiRNA; Kittler et al, 2005; Figure 6A and Supplementary
Figure S7). Here TCAB1, as a recently described DKC1 inter-
action partner necessary for proper trafficking of TERC
(Venteicher et al, 2009; Zhong et al, 2011), serves as a
reference for the extent of telomere shortening that can be
assigned as telomerase dependent. From HOT1- and TCAB1-
depleted, as well as control-transfected cells, metaphase
spreads were prepared 3 days post transfection and telomere
length was determined using quantitative telomeric FISH
(London˜o-Vallejo et al, 2001). Knockdown of both HOT1
and TCAB1 resulted in significant telomere shortening
(Figure 6B and Supplementary Figure S7) as indicated by
reduced FISH signals. Here the entire populations of FISH
signals shifted towards weaker signals, indicating that telo-
meres globally shortened in the absence of HOT1. In these
experiments the distributions after HOT1 and TCAB1 knock-
down were indistinguishable from each other, indicating that
their effect on telomere homeostasis is similar. Consistent
with this finding we also observed a significant increase in
the appearance of signal-free chromosome ends both upon
HOT1 and TCAB1 knockdown (Figures 6B and C, and
Supplementary Figure S7). We also obtained qualitatively
similar results by measuring telomere length after HOT1 and
TCAB1 knockdowns 3 days post transfection by a universal,
single telomere-elongation length analysis (STELA;
Figure 6D–F). Again, depletion of both HOT1 and TCAB1
led to shorter telomere length with a shortening of on average
700 and 600 bp, respectively. Given the short nature of
telomeres in this cell line (on average, 5 kb measured by
STELA) and the substantial contribution of variant repeats
and subtelomeric DNA to this value (Aubert et al, 2012), our
quantitative FISH and STELA data mutually confirm HOT1 as
a positive regulator of telomere length that quantitatively
behaves similar to the established telomerase pathway
member TCAB1.
Next we performed telomere length measurements after
HOT1 depletion at different time points. We reasoned that if
HOT1 is influencing telomere length in a mode dependent on
telomerase activity, its depletion should lead to a gradual loss
of telomeric tracts. To test this, we performed telomere length
measurements upon HOT1 depletion as a time course over
several days. Indeed, the telomeric signal was gradually
reduced in the absence of HOT1 (Figures 7A and B). Hence,
the telomere length changes observed due to manipulations
of HOT1 levels are in agreement with telomerase-dependent
changes.
In a complementary experiment, we transiently overex-
pressed FLAG–HOT1 in HeLa cells and analysed telomere
length 3 days after transfection. Consistent with the observed
telomere shortening upon HOT1 depletion, telomeres were
elongated upon its overexpression as indicated by an increase
of the entire population of FISH signals (Figures 7C and D).
The qFISH data suggests that the telomere length regulation
exerted by HOT1 is dependent on its telomere-binding
capacity. To test whether HOT1-dependent telomere
elongation indeed requires DNA binding, we used a
HOT1DHomeobox variant. In vitro-binding studies with
recombinant HOT1DHomeobox demonstrated that the
deletion of this domain indeed abolished binding to telomeric
50-TTAGGG-30 repeats (Figure 7E) and the lack of binding
also coincides with loss of telomeric localization in vivo
(Supplementary Figure S4b). To examine functional conse-
quences of DNA-binding-deficient HOT1 on telomere length
regulation, we overexpressed FLAG–HOT1DHomeobox in
HeLa cells. In contrast to telomere elongation upon
expression of full-length FLAG–HOT1, the expression of
FLAG–HOT1DHomeobox did not lead to an effect on telomere
length in comparison to the control (Figures 7C and D). Thus,
the HOT1–telomere interaction is essential for telomere elon-
gation. Collectively, these findings demonstrate that HOT1
acts as a positive regulator of telomere length. The fact that
Figure 6 HOT1 regulates telomere length similar to the telomerase pathway member TCAB1. (A) Verification of HOT1 knockdown efficiency
by western blot 48 h post transfection using the corresponding LAP cell line (Poser et al, 2008) as a reporter for protein expression. The TCAB1
knockdown was evaluated by quantitative PCR 24 h post transfection. (B) Quantification of telomere length by quantitative telomeric FISH after
transient knockdown of HOT1 and TCAB1. The distributions of fluorescence intensities, in arbitrary units of fluorescence (a.u.f.), of individual
telomeres from a total of 20 metaphases per treatment are displayed; the average intensity is indicated in red. For the gene-specific
knockdowns, changes of average telomere signal intensity relative to the RLuc (Renilla Luciferase) control are shown (left). Representative
FISH images are shown for each treatment and signal-free ends are indicated by arrows (right). Examples of individual chromosomes are
magnified and the respective chromosomes are marked by rectangles (right). Scale bars represent 5mm. (C) Summary of the quantification of
signal-free ends per metaphase after gene-specific knockdown. (D) Quantification of telomere length by universal STELA after transient
knockdown of HOT1 and TCAB1. The distributions of telomere length groups in kb of individual telomeres are displayed; the average length is
indicated in red and averages are stated with the respective s.e.m. Changes of average telomere length are shown relative to the RLuc (Renilla
Luciferase) control. (E) Raw data of STELA reactions for the quantification of telomere length. STELA products after gel electrophoresis,
transfer and hybridization from 12 individual reactions (lanes) per treatment are shown. Samples were loaded on two gels and were run in
parallel, represented by a gap within HOT1 esiRNA lanes. (F) Quantification of the frequency of short STELA products (o5 kb) relative to long
STELA products (45 kb). Five kilobases were used as a cut-off value based on this being the average telomere length as determined in the RLuc
control. Source data for this figure is available on the online supplementary information page.
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Figure 7 HOT1 acts as a positive regulator of telomere length. (A) Verification of HOT1 esiRNA knockdown efficiency using a HOT1-LAP cell
line (Poser et al, 2008) as a reporter for HOT1 expression by western blot after 2, 3, 4 and 6 days. Cells analysed after 4 and 6 days were
transfected twice: After the initial transfection, cells were transfected a second time on day 3 (72 h post transfection). All samples were run on
the same gel, irrelevant lanes were spliced out. (B) Quantification of telomere length by quantitative telomeric FISH after transient knockdown
of HOT1. The distributions of fluorescence intensities, in arbitrary units of fluorescence (a.u.f.), of individual telomeres from a total of 15–20
metaphases per treatment are displayed; the average intensity is indicated in red. Changes of average telomere signal intensity are shown
relative to the RLuc (Renilla Luciferase) control. (C) Verification of FLAG–HOT1 and FLAG–HOT1DHomeobox expression by western blot 48 h
post transfection. (D) Results of telomere length measurements after transient overexpression of FLAG–HOT1 and FLAG–HOT1DHomeobox.
The distributions of fluorescence intensities, in a.u.f., of individual telomeres from a total of 30 metaphases per treatment are displayed; the
average intensity is indicated in red. (E) Sequence-specific pull-down of FLAG–HOT1 and FLAG–HOT1DHomeobox. Proteins were incubated
with either telomeric repeats (50-TTAGGG-30) or a control oligonucleotide (50-GTGAGT-30). Source data for this figure is available on the online
supplementary information page.
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overexpression of HOT1 can stimulate telomere lengthening
further suggests that similar to TERTand TERC (Cristofari and
Lingner, 2006), HOT1 is a limiting factor, at least in this
cellular context.
TERT binding to chromatin is dependent on HOT1
The combined features of HOT1—direct binding to telomeric
dsDNA, preferential localization to telomeres in settings of
active processing, association with active telomerase, locali-
zation to the periphery of CBs and a positive effect on
telomere length—suggest a putative role of HOT1 in telomer-
ase recruitment. To test this possibility we assayed TERT
binding to chromatin in the absence of HOT1, based on a
previous experimental set-up that contributed to the identifi-
cation of TPP1 as a telomerase recruiter (Tejera et al, 2010).
To avoid potential convolutions of experimental results by the
presence of residual HOT1 protein, we established a HOT1
genetrap mouse. In Hot1Gt(pU-21T)346Card/(Gt(pU-21T)346Card mice,
the genetrap construct is inserted in the first intron of the
Hot1 gene. As the start codon resides in exon 2, we expected
that protein synthesis would be entirely abrogated (Figure 8A
and B). To verify this, we established mouse embryonic
fibroblasts (MEFs) of the different genotypes from littermate
embryos and performed immunofluorescence stainings with
our HOT1 antibody. While wild-type cells showed the typical
nuclear-punctuated pattern, HOT1 signals were absent in
Hot1Gt(pU-21T)346Card/(Gt(pU-21T)346Card MEFs (Figure 8C). Based
on this data and for the sake of simplicity, we will refer to
this as Hot1 / genotype. We then performed the chromatin
fractionation assay and could, as expected, detect TERT on the
chromatin fraction of wild-type MEFs, but not on chromatin
fractions from Tert / MEFs. Notably, the TERTsignal was also
absent when extracts of Hot1 / MEFs were used (Figure 8D),
reminiscent of previous data on TPP1 (Tejera et al, 2010). This
data indicate that HOT1 indeed contributes to telomerase
recruitment in vivo. Thus, HOT1 as a dynamic and differential
telomere-binding protein contributes to telomerase–telomere
association, mechanistically underlying its function as a positive
regulator of telomere length.
Discussion
We have adapted our SILAC-based DNA–protein interaction
screening technique to repetitive sequences as a straightfor-
ward and robust approach to identify novel interactions. In
addition to the established telomere-binding proteins and
their tight interaction partner, we have identified HOT1 as
the first direct telomere-binder that positively regulates telo-
mere length. HOT1 has previously been found as a telomere-
associated factor that localizes to some telomeres in HeLa
cells using the PICh approach (De´jardin and Kingston, 2009).
Interestingly, this is the only one of several recent large scale
studies searching for telomere-associated factors, which has
identified HOT1 (De´jardin and Kingston, 2009; Giannone
et al, 2010; Nittis et al, 2010; Lee et al, 2011), possibly
because also in this approach telomeric DNA was used as
bait, rather than using the shelterin components. While by
the PICh approach several hundreds of putative telomere-
associated factors were identified and the PICh technique is,
in general, addressing the global composition of (telomeric)
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Figure 8 TERT binding to chromatin is dependent on HOT1. (A) Schematic of the genetrap insertion in the Hot1 gene. (B) PCR genotyping.
Genomic DNA from wild-type, heterozygous and homozygous mice were analysed by PCR. Genotypes were confirmed using three primers
WT-F, WT-R and MUT-R. WT-F and WT-R amplify the wild-type allele (upper band), and WT-F and MUT-R amplify the genetrap allele (lower
band). (C) Immunofluorescence stainings of HOT1 on wild-type and Hot1Gt(pU-21T)346Card/(Gt(pU-21T)346Card MEFs (referred to as Hot1 / MEFs).
HOT1 foci (green) are absent in Hot1 / MEFs. DAPI (blue) is used as a nuclear counterstain. Scale bars represent 5 mm. (D) Subcellular
fractionation analysis of wild-type, Hot1 / and Tert / MEFs. Tubulin, PCNA and Histone3 serve as loading controls and to monitor the cell
fractionation. Source data for this figure is available on the online supplementary information page.
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chromatin, our approach is more apt to rapidly identify the
direct DNA binders and their tight interaction partners as
illustrated by the identification of HOT1. Thus, our in vitro
reconstitution assay seems particularly suited to discover
novel direct telomere binders.
In contrast to the other direct telomere-binding proteins,
TRF1 and TRF2, HOT1 does not localize to all telomeres and
the degree of telomere association varies between cell types.
While in situ telomerase activity is limited in HeLa cells to a
simple maintenance of short telomeres, it is increased in
mouse ES cells and is very high in mouse spermatogonia
and spermatocytes, where telomere length is reset to the very
long telomeres observed in mature sperm (Eisenhauer et al,
1997; Kozik et al, 1998; Yashima et al, 1998; Riou et al, 2005;
Tanemura et al, 2005). The fact that the nature of the HOT1
association with telomeres seems to be more transient in
normally cycling telomerase-positive cancer cells compared
to an intermediate degree of association in mouse ES cells,
and to a prominent and robust association with telomeres in
mouse spermatocytes, is consistent with promoting
telomerase-dependent telomere lengthening. This raises the
possibility that HOT1 selectively interacts with actively
processed telomeres. How exactly this interaction is
regulated and which precise step in telomere lengthening
HOT1 promotes will have to be addressed in the future.
While HOT1 localizes to a subset of telomeres together
with shelterin components, our HOT1 immunoprecipitation
experiments failed to establish any putative association
between HOT1 and shelterin complex members. Likewise,
we could not retrieve HOT1 after a POT1–IP, which is in
agreement with several other studies that searched for
shelterin-associated factors either by immunoprecipitation
or by bimolecular fluorescence complementation (Giannone
et al, 2010; Nittis et al, 2010; Lee et al, 2011). Our comparison
of the cocrystal structures of telomeric DNA with the HOT1,
TRF1 and TRF2 homeodomains indicates that while HOT1 is
shifted ‘down’ in 50-30 direction by one base towards the
following telomeric repeat, the binding sites are largely
overlapping. Hence, it is intriguing how these proteins
coexist at telomeres, how they compete for binding sites
and whether the shelterin proteins are found interspersed
on telomeres or whether there are discrete, mutually
exclusive patches along the telomeric tracts. This might
further contribute to answering the question how HOT1 is
selectively restricted to a subset of telomeres.
How does HOT1 fit into the current view of telomere
homeostasis? TCAB1 (WDR79/WRAP53) has been shown to
be required for proper localization of CAB box containing
scaRNPs to CBs, including TERC (Tycowski et al, 2009;
Venteicher et al, 2009). Similar to HOT1, TCAB1 acts as a
positive regulator of telomere length by recruiting TERC to
CBs (Venteicher et al, 2009). The telomere-binding properties
of HOT1 and its functional consequences, which are
quantitatively similar to those of TCAB1, suggest that HOT1
may act downstream of TCAB1. The putative mechanism
may involve recruiting telomerase-containing CBs to
telomeres, and thus promoting telomerase association with
telomeres, perhaps through additional interactions involving
TPP1 (Abreu et al, 2010; Tejera et al, 2010; Zaug et al, 2010).
The fact that overexpression of HOT1 further stimulates
telomere lengthening suggests that HOT1, similar to TERT
and TERC, is also a limiting factor. Therefore, the shelterin
and CST complexes, and the controlled levels of TERT, TERC
and HOT1, may all act cooperatively to define a mean
telomere length in the cell.
Our chromatin fractionation analysis indicates that HOT1 is
required for TERT recruitment to chromatin and, therefore,
qualifies as a telomerase recruitment factor. Similarly, TPP1
has been established as a telomerase recruiter likely by
(direct or indirect) interaction with TERT via its TEL patch
(Nandakumar et al, 2012), but based on our
immunoprecipitation data and previous studies there is no
indication for an interaction between HOT1 and TPP1. This
discrepancy may be explained by a step-wise telomerase
recruitment model, in which HOT1 simply acts before
TPP1. Previous reports have shown that POT1–TPP1 act as
a processivity factor for telomerase (Wang et al, 2007; Latrick
and Cech, 2010; Zaug et al, 2010). Enhanced in vivo
processivity would also result in an increased residence
time and a higher affinity to telomeres, thus explaining the
reduction of telomerase–telomere association in TPP1 knock-
down/knockout conditions. Given that HOT1 preferentially
localizes to telomeres in settings of high in situ telomerase
activity, one possibility is that HOT1 contributes to an ‘open’
telomere state that allows/promotes telomere elongation. In
such a model, HOT1 might contribute to rendering telomeres
accessible and/or contributes to the delivery of telomerase to
‘open’ telomeres. In this scenario, TPP1 would contribute
more prominently to maintaining telomerase at telomeres
and, thus, to processivity stimulation. Undoubtedly, the
mechanistic contribution of both factors and potential genetic
interactions are exciting avenues for future research.
Materials and methods
Cell culture
HeLa cells (Epitheloid carcinoma, cervix) and MEFs were cultivated
in 4.5 g/l glucose Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% fetal bovine serum, 100 U/ml penicillin and
100mg/ml streptomycin (Gibco) at 371C and 5% CO2. For SILAC
labelling, HeLa cells were incubated in RPMI 1640 (–Arg, –Lys)
medium containing 10% dialysed fetal bovine serum (Gibco)
supplemented with 84 mg/l 13C6
15N4 L-arginine and 50 mg/l
13C6
15N2 L-lysine (Sigma Isotec or Euriso-top) or the corresponding
nonlabelled amino acids, respectively. R1/E murine ES cells
were also grown in 4.5 g/l GlutaMAX DMEM containing sodium
pyruvate, but supplemented with 20% FBS, 50mM 2-mercapto-
ethanol (Invitrogen), LIF (MPI-CBG protein expression facility), as
well as 100 U/ml penicillin and 100mg/ml streptomycin (Gibco).
For SILAC labelling of R1/E cells, DMEM (–Arg, –Lys) medium
containing 20% dialysed FBS (Gibco) supplemented with 40 mg/l
13C6
15N4 L-arginine and 80 mg/l
13C6
15N2 L-lysine (Sigma Isotec
or Euris-top) or the corresponding nonlabelled amino acids,
respectively, was used. Cells were collected and nuclear extracts
were prepared as described (Butter et al, 2010).
Telomere pull-down
Chemically synthesized oligonucleotides (Table II; Metabion) were
annealed and polymerized by T4 ligase (Fermentas) and biotiny-
lated with biotin–dATP (Invitrogen) by Klenow fragment
(Fermentas) following the manufacturer’s instructions. Twenty-
five microgram baits were immobilized on 750 mg paramagnetic
streptavidin beads (Dynabeads MyOne C1, Invitrogen) and subse-
quently incubated with either 400mg of SILAC-labelled nuclear
extract or 20 ml of supernatants of crude E. coli lysates (3mg/ml)
in PBB buffer (150 mM NaCl, 50 mM Tris–HCl pH 8.0, 10 mM MgCl2,
0.5% NP-40, Complete Protease Inhibitor without EDTA (Roche))
for 2 h at 41C on a rotation wheel. After three washes with PBB
buffer bead fractions were pooled, bound proteins boiled at 801C in
1 LDS buffer (Invitrogen) and separated on a 4–12% gradient gel
(Novex, Invitrogen; Butter et al, 2010).
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MS data acquisition
In-gel digestion and MS analysis was performed essentially as
previously described by Butter et al, 2010. Peptides were desalted
on StageTips and analysed by nanoflow liquid chromatography on
an EASY-nLC system from Proxeon Biosystems coupled to a LTQ-
Orbitrap XL or a Orbitrap-Velos (Thermo Electron). Peptides were
separated on a C18-reversed phase column (15 cm long, 75 mm inner
diameter, packed in-house with ReproSil-Pur C18-AQ 3 mm resin
(provided by Dr Maisch)) directly mounted on the electrospray ion
source. We used a 107-min gradient from 2 to 60% acetonitrile in
0.5% acetic acid at a flow of 200 nl/min. The LTQ-Orbitrap XL was
operated with a Top5 MS/MS spectra acquisition method in the
linear ion trap per MS full scan in the Orbitrap, while for the
Orbitrap-Velos a Top10 acquisition method with HCD fragmentation
was used.
MS spectrum and data analysis
The raw files were processed with MaxQuant (Cox and Mann, 2008)
and searched with the Mascot search engine (Matrix Science)
against IPI human v3.37 protein database concatenated with a
decoy of the reversed sequences. Carbamidomethylation was set
as fixed modification, while methionine oxidation and protein
N-acetylation were considered as variable modifications. The
search was performed with an initial mass tolerance of 7 p.p.m.
mass accuracy for the precursor ion and 0.5 Da for the MS/MS
spectra obtained with CID fragmentation and 20 p.p.m. for the MS/
MS spectra in the HCD fragmentation mode. Search results were
processed with MaxQuant filtered with a false-discovery rate of
0.01. Before statistical analysis, known contaminants and reverse
hits were removed. The protein ratios of a ‘forward’ experiment and
the ‘reverse’ experiment were plotted in R (prerelease version
2.8.0). Only proteins identified with at least two unique peptides
and two quantitation events were plotted for the telomere
pull-down (quality filter).
Recombinant protein expression and deletion variant
construction
The HOT1 clone was obtained from the ORFeome collection
(IOH40784, Invitrogen). The sequence was subcloned into SLIC-
compatible pETM44 or pETM14 vector via SLIC cloning (Li and
Elledge, 2007; Scholz et al, 2013) and was expressed in E. coli
Rosetta at 181C. E. coli extracts with overexpressed recombinant
proteins were used for binding studies on variant DNA motives. For
crystallization, protein was purified under nondenaturing
conditions using Ni2þ sepharose high-performance columns (GE
Healthcare) followed by size-exclusion chromatography on
Superdex 75 (GE Healthcare), using 150 mM NaCl and 20 mM
Tris–HCl (pH 7.5) as a running buffer.
The HOT1 ORFeome clone was LR recombined into a gateway
compatible pcDNA3.1 vector with N-terminal FLAG-tag (gift of
Christian Brandts). A FLAG-tagged HOT1 homeobox deletion var-
iant was constructed by PCR amplification of the pcDNA3.1-FLAG
vector using primers with site-specific overhangs (Table III;
Metabion) following the QuickChange II Site-directed mutagenesis
kit protocol (Stratagene; Zheng et al, 2004). Point mutants were
generated similarly using the QuickChange protocol. For expression
in ES cells, constructs were subcloned into a pCAGGS vector. The
constructs were sequence verified using an Applied Biosystems
3730 Genetic Analyzer (Applied Biosystems), according to the
manufacturer’s instructions.
Crystallization and structure determination
The complex of human HOT1 DBD and double-stranded telomeric
DNA (50-TTAGGGTTAGGGTTA-30) was obtained as follows:
synthetic single-strand complementary oligonucleotides (Table IV;
Eurofins MWG) were dissolved in water and mixed to yield a 5-mM
stock solution. For double-strand annealing, this solution was
heated to 961C for 10 min and allowed to cool down to room
temperature (RT) in the switched-off heat block within 2–3 h. This
solution was mixed in a 1–1.2 M excess with a solution of purified
HOT1 DBD at 10 mg/ml and incubated on ice for 10 min. Crystals
of the complex were grown at 41C by sitting-drop vapour diffusion
from drops formed by mixing equal volumes of the complex
solution and the crystallization condition 24% PEG 3350, 100 mM
Na Acetate (pH 4.5) and 100 mM KSO4. For data collection, crystals
were cryoprotected by soaking in a mother liquor supplemented
with 20% glycerol and was flash-frozen in liquid nitrogen.
Diffraction data were collected at the PXII beam line of the Swiss
Light Source (SLS; Villigen, Switzerland) and processed using
XDS (Kabsch, 1993). The structure was solved by molecular
replacement with the programme PHASER (McCoy et al, 2007),
using the NMR structure of the HOT1 DBD as a search model
(PDB entry 2CUF). Model building and refinement was carried out
with Phenix (Afonine et al, 2005) and COOT (Emsley and Cowtan,
2004), and models were validated with the programme Molprobity
(Davis et al, 2007).
Table II Oligonucleotides used for pull-down experiments
No Sequence motif (50-30) Primer sequence (50-30)
1a TTAGGG for TTAGGGTTAGGGTTAGGGTTAGGGTTAGGGTTAGGGTTAGGGTTAGGGTTAGGGTTAGGG
1b TTAGGG rev AACCCTAACCCTAACCCTAACCCTAACCCTAACCCTAACCCTAACCCTAACCCTAACCCT
2a GTGAGT for TTGACAGTGAGTGTGAGTGTGAGTGTGAGTGTGAGTGTGAGTGTGAGTGTGAGTGTGAGT
2b GTGAGT rev AAACTCACACTCACACTCACACTCACACTCACACTCACACTCACACTCACACTCACTGTC
3a TTAGGC for TTAGGCTTAGGCTTAGGCTTAGGCTTAGGCTTAGGCTTAGGCTTAGGCTTAGGCTTAGGC
3b TTAGGC rev AAGCCTAAGCCTAAGCCTAAGCCTAAGCCTAAGCCTAAGCCTAAGCCTAAGCCTAAGCCT
4a TTGGGG for TTGGGGTTGGGGTTGGGGTTGGGGTTGGGGTTGGGGTTGGGGTTGGGGTTGGGGTTGGGG
4b TTGGGG rev AACCCCAACCCCAACCCCAACCCCAACCCCAACCCCAACCCCAACCCCAACCCCAACCCC
5a TCAGGG for GTCAGGGTCAGGGTCAGGGTCAGGGTCAGGGTCAGGGTCAGGGTCAGGGTCAGGGTCAGG
5b TCAGGG rev ACCCTGACCCTGACCCTGACCCTGACCCTGACCCTGACCCTGACCCTGACCCTGACCCTG
6a TGAGGG for GTGAGGGTGAGGGTGAGGGTGAGGGTGAGGGTGAGGGTGAGGGTGAGGGTGAGGGTGAGG
6b TGAGGG rev ACCCTCACCCTCACCCTCACCCTCACCCTCACCCTCACCCTCACCCTCACCCTCACCCTC
Table III Oligonucleotides used for QuickChange
No Cloning/BAC engineering purpose Primer sequence (50-30)
1 HOT1 homeobox domain deletion, forward primer CTGCGACGAGGGAGTGCCAATATTGAAGCAGCAATCCTGG
2 HOT1 homeobox domain deletion, reverse primer TGCTTCAATATTGGCACTCCCTCGTCGCAGTCGGAAAGTA
Table IV Oligonucleotides used for crystallization
No
Telomeric DNA oligos
for crystallization Primer sequence (50-30)
1 T1; forward oligo CTGTTAGGGTTAGGGTTAG
2 T2; reverse oligo TCTAACCCTAACCCTAACA
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The alignment of the HOT1, TRF1 and TRF2 homeobox domain
sequences was done in two steps. First, a secondary structure-based
alignment was generated using the programme Chimera
(www.cgl.ucsf.edu/chimera) followed by feeding it into the web
application Espript (espript.ibcp.fr) for a simple sequence align-
ment scoring and colouring.
Antibody production
His-MBP-tagged HOT1 (pETM44 vector construct) was expressed in
E. coli Rosetta at 181C in a fermentation tank. Cell pellet was lysed
with Avestin and the soluble fraction subjected to affinity purifica-
tion using Ni-sepharose. The elution fraction was concentrated with
an Amicon Ultra 15 concentrator column and dialysed into buffer
containing 50 mM K2PO3, 20 mM NaCl, 10% glycerol, 1 mM TCEP
and protein inhibitors. Purified MBP-HOT1 was injected into rabbits
for immunization and the rabbits were ultimately sacrificed. The
antibody was affinity purified using His-MBP-HOT1 and MBP
immobilized on HiTRAP desalting columns (GE Healthcare). First,
the serum was applied to the His-MBP-HOT1 column, eluted and
then applied to the MBP column. The flow trough was quantified
and used for subsequent experiments.
Purified MBP-HOT1 was injected into mice for immunization and
the mice were ultimately sacrificed. Immortalized hybrid cells
(hybridomas) were obtained by the fusion of B cells from the spleen
of an immunized mouse with a myeloma cell line, which itself does
not produce antibodies, using PEG and AH selection (Sigma
Aldrich). Hybridoma clones were generated and screened using
the Meso Scale Discovery platform (Meso Scale Diagnostics) by
comparing affinity to His-MBP-HOT1 and His-MBP-Katanin as an
unspecific negative control. Positive clones were subcloned by
limiting dilution and retested using the MSD platform. Based on
the subcloned hybridoma cell lines, antibodies were purified using
HiTRAP protein G columns (GE Healthcare) followed by acid
elution.
Chromatin immunoprecipitation
Cells were crosslinked with 1% formaldehyde (Thermo Scientific)
for 10 min at 371C, and the reaction was stopped by adding glycine
to a final concentration of 0.125 M for 5 min at RT. Nuclei were
prepared from fixed and washed cells by homogenization in cell
lysis buffer (5 mM PIPES pH 8, 85 mM KCl, 0.5% NP-40) and
centrifugation at 1800 g for 10 min. Finally, nuclei were lysed in
900 ml nuclei lysis buffer (50 mM Tris–HCl pH 8, 10 mM EDTA pH 8,
1% SDS) and lysates were sonicated for 30 min (30 s on/30 s off) in
a Diagenode water-bath sonicator at speed 5. Following a centrifu-
gation at 14 000 r.p.m. for 10 min, the cleared supernatants were
snap-frozen in liquid nitrogen and stored at  801C. Sonication
efficiency was routinely monitored by DNA gel electrophoresis to
ensure that the bulk of DNA fragments was between 100 and 500 bp.
Sonicated chromatin containing 50mg DNA was diluted 10 times
in ChIP dilution buffer (16.7 mM Tris–HCl pH 8, 167 mM NaCl,
1.2 mM EDTA pH 8, 1.1% Triton X-100, 0.01% SDS) and precleared
for 2 h, rotating at 41C, with 20ml blocked beads (Dynabeads Protein
A beads (Invitrogen) incubated for 2 h with 5 mg/ml BSA) before
the overnight incubation with 5mg of antibody. The following
antibodies were used: mouse anti-HOT1 (MPI-CBG Antibody
Facility), rabbit anti-TRF2 (NB110-57130, Novus), rabbit IgG
(ab37415, Abcam) or mouse anti-GFP (ab1218, Abcam)). The
bound material was recovered after a 2 h incubation, rotating at
41C, with 30ml blocked beads. The beads were washed for 10 min in
each of the following wash buffers: low-salt buffer (20 mM Tris–HCl
pH 8, 150 mM NaCl, 2 mM EDTA pH 8, 1% Triton X-100, 0.1% SDS),
high-salt buffer (20 mM Tris–HCl pH 8, 500 mM NaCl, 2 mM EDTA
pH 8, 1% Triton X-100, 0.1% SDS), LiCl buffer (10 mM Tris–HCl pH
8, 0.25 M LiCl, 1 mM EDTA pH 8, 1% NP-40, 1% Na deoxycholate)
and twice, 5 min each, in TE. ChIPed material was eluted by two
15 min incubations at RT with 225ml elution buffer (0.1 M NaHCO3,
1% SDS). Chromatin was reverse-crosslinked by adding 18ml of
5 M NaCl and incubated overnight at 651C, and DNA was
submitted to RNase and proteinase K digestion and extracted by
phenol–chloroform.
Purified DNA recovered by ChIP was denatured in 0.2 M NaOH by
heating to 1001C for 10 min and spotted onto a positively charged
Biodyne B nylon membrane (Pall, VWR). Membranes were hybri-
dized at 421C in 6 SSC, 0.01% SDS, 0.1% milk with 20 pmol of
DIG-labelled telomeric C-rich LNA probe (36 bp, Exiqon). Following
hybridization washes (twice 5 min in 2 SSC, 0.01% SDS, and
once 2 min in 0.1 SSC, 0.01% SDS), the signal was revealed using
the anti-DIG-AP antibodies (Roche) and CDP-Star (Roche) following
the manufacturer’s instructions. Images were obtained using the
Luminescent image analyser LAS-4000 mini (GE Healthcare).
Following the detection of a telomeric signal, membranes were
stripped twice for 15 min each in 0.5% SDS at 601C and twice for
15 min each in 0.2 N NaOH, 0.1% SDS at 371C. Stripped membranes
were then hybridized at 651C in 6 SSC, 0.01% SDS, 0.1% milk
with P32-random-primed labelled total genomic DNA from HeLa
cells. Following hybridization washes (10 min in 2 SSC, 0.01%
SDS, 10 min in 0.5 SSC, 0.01% SDS and 10 min in 0.1 SSC,
0.01% SDS) the signal was revealed using the phosphorimager and
an image obtained by the Typhoon scanner.
Immunofluorescence and immunoFISH stainings on cycling
cells
For immunofluorescence stainings, cells were seeded 24 h before
the treatment on either glass coverslips (0.17 mm, assorted glass,
Thermo Scientific) or in LabTek II chambered coverglass chambers
(Labtek). After a brief wash with 1x PBS cells were fixed in 10%
formalin solution (Sigma Aldrich) for 10 min at RT, followed by two
washes with 1PBSþ 30 mM glycine. Cells were then permeabi-
lized with 1PBSþ 0.5% Triton X-100 for 5 min at 41C, followed by
again two washes with 1PBSþ 30 mM glycine. Afterwards, cells
were blocked in blocking solution (1PBS, 0.2% fish-skin gelatine
(Sigma Aldrich)) for 15 min at RT. Primary antibodies were diluted
in blocking solution and incubated for 1 h at RT. The following
primary antibodies were used: mouse anti-HOT1 (MPI-CBG
Antibody Facility, 1:1000), rabbit anti-Coilin (sc-32860, Santa
Cruz, 1:500), and goat anti-GFP (MPI-CBG Antibody Facility,
1:2000). Cells were washed three times for 3 min each in blocking
solution followed by a 30-min incubation at RT with secondary
antibodies, which were diluted in blocking solution. As secondary
antibodies, fluorescent-labelled donkey anti-rabbit-IgG or donkey
anti-mouse-IgG antibodies with either Alexa488, Alexa555,
Alexa594 or Alexa647 as fluorochromes (1:500, Invitrogen) were
used. After three final washes for 3 min each in blocking solution,
slides were briefly rinsed in distilled water and mounted using DAPI
Prolong Gold Antifade Reagent (Invitrogen). In the case of Labtek
chambers, samples were incubated for 5 min with blocking solution
containing 1mg/ml DAPI, followed by one wash in blocking solution.
If FISH stainings were combined with immunofluorescence stain-
ings (immunoFISH), the FISH labelling was carried out directly after
the IF protocol. Cells were post-fixed in 10% formalin solution
(Sigma Aldrich) for 10 min at RT, followed by three washes in 70, 90
and 100% ethanol for 5 min each, followed by a standard telomeric
FISH protocol as previously described.
All images were acquired with a DeltaVision Core Microscope
(Applied Precision, Olympus IX71 microscope) using a 100 /1.4
UPlanSApo oil-immersion objective. Z-stacks (0.2mm optical sec-
tions) were collected and deconvolved using softWoRx (Applied
Precision). Z-stacks were reconstructed in 3D using Imaris
(Bitplane), and colocalization events were determined for signals
above the background using the colocalization function.
esiRNA synthesis
The detailed protocol of esiRNA production has been previously
published (Kittler et al, 2005). Briefly, optimal regions for designing
esiRNAs were chosen using the Deqor design algorithm (Henschel
et al, 2004) in order to fulfill two criteria: to obtain the most efficient
silencing trigger in terms of silencing efficiency, and to get lowest
chances to cross-silence other genes. The most favourable
fragments were used to design gene-specific primers (Table V)
using the Primer3 algorithm (http://frodo.wi.mit.edu/cgi-bin/
primer3/primer3_www.cgi). Two esiRNAs for HOT1 and one each
for TRF1 and TCAB1 were designed and synthesized. PCR products
for the esiRNA production were sequenced using an Applied
Biosystems 3730 Genetic Analyzer (Applied Biosystems) according
to the manufacturer’s instructions. All positions of sequence trace
files were confirmed by manual inspection.
esiRNA and plasmid transfection
For all transfections, HeLa cells were seeded in six-well plates
(40 000 cells per well corresponding to 9.6 cm2) dish and incubated
overnight before transfection. For esiRNA transfection, 30ml
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Oligofectamine (Invitrogen) were diluted in 250 ml OptiMEM
(Invitrogen) and incubated for 5 min at RT. In a separate tube,
2 mg esiRNA were diluted in 250ml OptiMEM. Solutions were
combined, mixed and incubated for 20 min at RT after which the
transfection mix was evenly distributed over the dish.
The FLAG–HOT1 and the homeobox deletion variant construct
were transfected using either Effectene (Qiagen) or Lipofectamine
2000 (Invitrogen) as the transfection reagent according to the
manufacturers’ instructions.
Telomeric quantitative FISH
For metaphase preparation, cells were incubated for 4 h with
200 nM nocodazole in order to induce mitotic arrest. A hypotonic
shock was achieved in 0.03 M sodium citrate at 371C for 40 min.
Cells were fixed in an ethanol/acetic acid solution (3:1) and washed
three times in this fixing reagent. Metaphase spreads were obtained
by dropping suspensions of fixed cells onto clean glass slides.
The QFISH procedure was carried out as described, using an
Alexa488-O-O-(CCCTAA)3 or Cy3-O-O-(CCCTAA)3 PNA probe
(Panagene) (London˜o-Vallejo et al, 2001).
Telomeric signals were quantified using the iVision software
(Chromaphor). Telomere signals were segmented manually and
average pixel intensities from every segment were quantified. For
each metaphase, the average background intensity was determined
and subtracted from individual telomere signals. Statistical analyses
were done using Student’s t-test.
The number of signal-free ends per metaphase was determined by
manual inspection of the same metaphase images that were used for
telomere signal-intensity quantification. Statistical analyses were
done using Student’s t-test.
Universal STELA
One hundred picogram of NdeI/MseI (NEB)-digested DNA were
amplified according to the previously published Universal STELA
PCR amplification protocol (Bendix et al, 2010) with the following
cycling conditions: 681C for 5 min, 951C for 2 min, 26 cycles of 951C
for 15 s, 581C for 30 s and 721C for 12 min, and 721C for 15 min. In
brief, 10 ng of DNA were digested with 0.4 units of NsdeI and 0.4
units of MseI, annealed at 161C overnight to 4.2mM of both 42-mer
(50-TGTAGCGTGA-AGACGACAGAAAGGGCGTGGTGCGGACGCGGG-30)
and 11þ 2-mer (50-TACCCGCGTCCGC-30) panhandle-oligos with 1.3
units of T4 ligase (NEB) and ligated to 1 nM of telorette3 (50-TGCTC
CGTGCATCTGGCATCCCTAACC-30) at 351C over night. One hundred
picogram of ligated DNA was then used for PCR amplification with
0.1 mM of Adapter (50-TGTAGC-GTGAAGACGACAGAA-30) and of
Teltail (50-TGCTCCGTGCATCTGGCATC-30) primers by the Failsafe
Enzyme with the FailSafe buffer premix H (Epicentre). The PCR
products were resolved on a 1.2% agarose gel, blotted onto a nylon
membrane by capillary osmosis and hybridized at 421C over night
to a DIG-labelled telomeric C-rich LNA probe (36 bp, Exiqon). The
blots were then washed with Maleic Acid/Tween solution and DIG
signal was revealed with anti-DIG-AP antibody (1:20 000, Roche)
and CDP-star solution (Roche) according to the manufacturer’s
instructions. Statistical analyses were done using Student’s t-test.
Protein immunoprecipation
Immunoprecipitations were carried out using the Dynabeads
Protein G or A immunoprecipitation kit (Invitrogen). Fifty microlitre
of beads were treated with 10mg rabbit anti-HOT1, mouse anti-
HOT1 (both MPI-CBG Antibody Facility), rabbit IgG (sc-66931,
Santa Cruz; 2729s, Biolabs) or mouse IgG (ChromPure, Jackson
ImmunoResearch) in PBB buffer (150 mM NaCl, 50 mM Tris–HCl pH
8.0, 10 mM MgCl2, 0.5% NP-40, Complete Protease Inhibitor–EDTA
(Roche)) and subsequently incubated with 400mg HeLa nuclear
extract (SILAC-labelled if followed by MS analysis) for 2 h at 41C on
a rotation wheel, followed by three washes with PBB buffer. For MS,
bead fractions were pooled, bound proteins were eluted and sepa-
rated on a 4–12% gradient gel (Novex, Invitrogen). For co-IP
experiments followed by western blot, bound proteins were simply
eluted and subjected to western blot analysis.
Western blot
For western blot samples were boiled in Laemmli buffer (Sigma
Aldrich) and subjected to SDS–PAGE (NuPage 4–12% Bis-Tris gels;
Invitrogen). Gels were blotted to nitrocellulose (Protran; Schleicher
& Schuell), blocked in 5% nonfat milk in PBST (PBS containing
0.1% Tween-20) for 1 h at RT and incubated over night at 41C with
primary antibody. The following primary antibodies were used:
mouse anti-GFP (Roche Diagnostics, 1:4000 dilution), mouse anti-
DM1alpha tubulin (MPI-CBG Antibody Facility, 1:50 000 dilution),
mouse anti-Ku70 (sc17789, Santa Cruz, 1:1000 dilution), mouse
anti-FLAG (M2, Sigma Aldrich, 1:5000) mouse anti-PCNA (sc-9847,
Santa Cruz, 1:1000), mouse anti Histone3 (ab, 1791, Abcam,
1:10 000) and rabbit anti-TERT (gift from Madalena Tarsounas,
1:2000). The next day, membranes were washed three times for
10 min each in 5% milk PBST and were incubated for 1 h at RT with
secondary antibody (goat anti-mouse antibody conjugated to horse-
radish peroxidase, Bio-Rad, 1:4000, or donkey anti-mouse IRDye
800CW or donkey anti-rabbit IRDye 800CW, both LI-COR Odyssey,
1:15 000). Membranes were washed three times for 10 min each in
PBST followed by one PBS wash. Bands were visualized with
enhanced chemiluminescence Western Blotting Detection
Reagents (GE Healthcare) or with the LI-COR Odyssey imaging
system. For detection of His-tagged HOT1, TRF1 and TBP, the
Penta-His HRP Conjugate Kit (Qiagen) was used according to the
manufacturer’s instructions. As a molecular weight standard,
Spectra Multicolor Broad Range Protein Ladder (Fermentas),
Seablue 2 (Invitrogen) and MagicMark XP Western Protein
Standard (Invitrogen) were used.
Immunoprecipitation of telomerase activity and quantitative
TRAP assay
For the immunoprecipitation of telomerase activity HeLa cells were
lysed in lysis buffer (50 mM Tris–HCl (pH 8.0), 150 mM NaCl and
1% NP-40 supplemented with Complete Protease Inhibitor–EDTA
(Roche)) for 30 min on ice followed by a 30 min centrifugation step
in a table-top centrifuge at 41C and 20 000 g. Per IP assay, 25ml of
magnetic protein G beads (Invitrogen) were used. Beads were
washed three times with 1PBS before use and incubated with
5 mg/ml BSA (in 1PBS) for 1 h at 41C on a rotating wheel, while
lysates were precleared with uncoated beads for 1 h at 41C on a
rotating wheel. Per IP assay, 1 mg lysate was incubated with 5 mg
rabbit anti-HOT1 (MPI-CBG Antibody Facility), rabbit anti-DKC1
(ab64667, Abcam), rabbit anti-TRF1 (ab1423, Abcam), rabbit anti-
TRF2 (NB110-57130, Novus), rabbit anti-TBP (sc-273, Santa Cruz),
rabbit anti-YY1 (ab12132, Abcam), rabbit anti-STAT3 (9132, Cell
Signaling), rabbit anti-Histone3K4tri-methylated (07-473, Upstate
Antibodies), rabbit anti-CENP-B (ab25734, Abcam) or rabbit IgG
(sc-66931, Santa Cruz) in PBS for 2 h at 41C on a rotating wheel.
BSA-coated beads were added, followed by a second incubation for
Table V Oligonucleotides used for esiRNA production
No Gene name ENSEMBL ID Forward primer (50-30) Reverse primer (50-30)
1 Renilla Luciferase GATAACTGGTCCGCAGTGGT CCATTCATCCCATGATTCAA
2 HOT1 (1st esiRNA) ENSG00000147421 ATTTCCCAAGCAGTTGTTGC CCAGATCTGACAGCTTTTTGC
3 HOT1 (2nd esiRNA) ENSG00000147421 GTTACCTCC CTGAAAGTATA GTTGGTTAT TATTTACTGGG
6 TRF1 ENSG00000147601 TGGCAACTTTAAAGAAGCAGAA AGCTTCAGTTTCCATTTCAACA
7 TCAB1 ENSG00000141499 CGAATCGAGGAGCAAGAACT GGGCTGAGGACATCAGAGAA
Please note that esiRNA–template production consists of two consecutive PCRs. In the table only the transcript-specific primers for the first
PCR round are listed. Universal tags have to be added to all primers that allow amplification with universal T7 primers in the second PCR
round. The universal tags are 50-TGTAAAACGACGGCCAGT-30 (forward) and 50-AGGAAACAGCTATGACCAT-30 (reverse). The universal T7
primers are 50-GCTAATACGACTCACTATAGGGAGAG-30 (forward) and 50-GCTAATACGACTCACTATAGGGAGAC-30 (reverse).
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2 h at 41C on a rotating wheel. Beads were then washed once with
PBS, twice with lysis buffer and again once with PBS and finally
recovered in 75ml Chaps buffer (Chemicon).
The quantitative TRAP assay was carried out using GoTaq
qPCR Master Mix (Promega) and both the TS (50-AATCCGTCGAG
CAGAGTT-30) and ACX primer (50-GCGCGGCTTACCCTTACCCTTAC
CCTAACC-30) at 200 nM. The reaction was run on a Mx3000p
real-time PCR system (Stratagene) with the following protocol:
251C for 20 min, 951C for 10 min and 32 cycles with 951C for 30 s,
601C for 30 s and 721C for 1 min. Statistical analyses were done
using Student’s t-test.
For verification that signals were due to the presence of the
characteristic TRAP ladder, samples were run on a 20% precast
TBE gel (Invitrogen) for 2 h at 200 V. For size reference, the
GeneRuler Ultra Low Range DNA Ladder (Fermentas) was used.
The gel was stained with EtBr for visualization.
Quantitative real-time PCR
For quantification of TCAB1 mRNA levels RNA was extracted with
the RNeasy kit (Qiagen), including DNaseI digestion and from the
eluted RNA cDNA was synthesized using the SuperScript III first-
strand synthesis kit with oligodT according to manufacturer’s
instructions. qPCR primers (Table VI) were used at 70 nM concen-
tration together with the Absolute qPCR SYBR green mix (Abgene)
on a Mx3000p real-time PCR system (Stratagene). Target gene
mRNA levels were normalized against quantification of GAPDH
mRNA levels for housekeeping.
Statistical analyses were done using student’s t-test.
BAC TransgeneOmics
The following BACs (bacterial artificial chromosomes) were used in
this study: human HOT1 RP11-789B24 (Invitrogen), DKC1 RP11-
107C18, Coilin RP23-375L19 and POT1 CTD-3053M7 and mouse
TRF1 RP24-402F23 (BACPAC Resource Center). A LAP (localization
and affinity purification) cassette was inserted as a C-terminal
fusion using recombineering. Isolated BAC DNA was transfected
and selected for stable integration as described (Poser et al, 2008).
The BAC RP11-789B24 does not cover the entire HOT1 gene and was
complemented by insertion of a cDNA fragment covering the
missing coding and 30-UTR sequence (Table VII).
Immunofluorescence stainings on testes chromosome
spreads and testes sections
Testes were isolated from wild-type 129T2/SvEms male mice,
between 4–6 weeks old. To prepare chromosome spreads, the
tunica albuginea was detached and the seminiferous tubules were
incubated in 500ml of 1 mg/ml Collagenase Type I (Gibco) in PBS
for 10 min at 321C. The tubules were agitated slightly, and the liquid
was removed in order to remove a proportion of interstitial cells. A
fresh 500ml aliquot of 1 mg/ml collagenase was added and incu-
bated at 321C for 30 min, disaggregating by pipetting every 10 min.
The cells were spun at 2000 r.p.m. for 5 min at 41C. The pellet was
resuspended in 1 ml cold PBS and filtered through a 40mm nylon
membrane to create a single-cell suspension.
Fifteen microlitre of fixation and permeabilization solution (1%
PFA, 5 mM sodium borate pH 8.5, 0.2% Triton X-100) were added to
each well (Ø 7 mm) on a 10-well glass slide (StarFrost coating,
Engelbrecht). An ImmEdge pen (Vector Laboratories) was used to
circle the wells and prevent leakage. The cells were diluted 1:5 into
cold 100 mM sucrose in 1PBS for 2–3 min to allow hypertonic
swelling. One to two microlitre of cell suspension were added to
each well. The slides were incubated in a humidified chamber for
30 min, followed by 2–3 h of drying in a laminar hood or on the
bench at 221C. The slides were washed briefly three times in 0.5%
Photo-Flo (Kodak) then once in distilled water.
To prepare testes tissue sections, whole testes were immersed in
O.C.T Compound (Tissue-Tek 4583) in specimen molds (Tissue-Tek
4566 Cyromold 15 mm 15 mm 5 mm) and frozen at  801C.
Seven-micrometer sections were cut using a Leica CM1900 and
placed on microscope slides (StarFrost K078; 76 26 mm). Sections
were fixed using 4% formaldehyde (Sigma F8775) in 1PBS for
15 min at 221C and permeabilized using 0.15% Triton X-100 for
10 min at 221C and washed twice in 1PBS.
To perform immunofluorescence for both chromosome spreads
and tissue sections, blocking solution (0.2% fish gelatin (Sigma) in
PBS 0.1% Tween-20) was added for 1 h at RT. Primary antibodies
were added for 16 h at RT. The following primary antibodies were
used: rabbit anti-HOT1 (MPI-CBG Antibody Facility, 1:1000), rabbit
anti-TRF2 (sc-9143, Santa Cruz, 1:100) and mouse anti-SYCP3 (as
previously described (Adelfalk et al, 2009)). The cells were washed
3 in blocking solution for 10 min each and secondary antibodies
(goat anti-rabbit Alexa555 or goat anti-mouse Alexa488 at 1:500,
Invitrogen) were added for 1 h at RT. After 3washing in blocking
solution for 10 min each, Vectashield (Vecta Laboratories) containing
1mg/ml DAPI was added and a glass cover slip was placed on top of
the wells and sealed closed. Slides were stored at  201C.
Images were acquired with a DeltaVision Core Microscope
(Applied Precision, Olympus IX71 microscope) using a 100 /1.4
UPlanSApo oil-immersion objective. Z-stacks (0.2–0.5 mm optical
sections) were collected and deconvolved using softWoRx (Applied
Precision). Z-stacks were reconstructed in 3D using Imaris
(Bitplane) and colocalization events were determined for signals
above the background using the colocalization function. For ima-
ging of entire tubules, separate images were acquired as one panel
and stitched together using the stitch function in softWoRx for
visualization.
Hot1Gt(pU-21T)346Card/(Gt(pU-21T)346Card mice and generation of
MEFs
C57BL/6-CBA-Hot1Gt(pU-21T)346Card/þ embryos were retrieved from
the Center for Animal Resources and Development and are based on
the Exchangeable Gene Trap Clones system using the exchangeable
pU21 trap vector (Araki et al, 2009). Live animals were retrieved by
embryo transfer and were outcrossed for several generations against
C57BL/6 wild-type animals. MEFs were generated from littermate
embryos at E13.5 by crossing C57BL/6-Hot1Gt(pU-21T)346Card/þ
animals with each other.
Genotyping PCR
For genotyping of Hot1Gt(pU-21T)346Card/(Gt(pU-21T)346Card mice, primers
were designed to amplify the wild-type and mutant allele in one
PCR reaction, both sharing the same forward primer. The PCR was
carried out with a reaction containing 2.5ml 10PCR buffer, 0.8ml
Table VI Oligonucleotides used for quantitative PCRs
No Gene name ENSEMBL ID Forward primer (50-30) Reverse primer (50-30)
1 GAPDH ENSG00000111640 CAGCCTCAAGATCATCAGCA TGTGGTCATGAGTCCTTCCA
2 TCAB1 ENSG00000141499 AGCCAGACACCTCCTACGTG GGTTGAAGCCACAGAAGAGC
Table VII Oligonucleotides used for cloning and BAC engineering
No Cloning/BAC engineering purpose Primer sequence (50-30)
1a HOT1 BAC stitching primers to add missing
CDS and 30-UTR, forward primer
CGATTTACCTGGAGAAAGGAGTGCCTGGCTGTTATGGAAAGT-TACTTCAATGAGAATCAA
TACCCAGATG
1b HOT1 BAC stitching primers to add
missing CDS and 30-UTR, reverse primer
TATAATACAGCATTTATGATATTCTAAAGTACTTTTAGAGAT-AGAACCAACCCTGTGCTG
CTACATTGAA
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50 mM MgCl2, 0.2ml 25 mM dNTP mix, 2ml 10 mM WT-F primer,
each 1ml 10 mM WT-R and MUT-R primers, 1 ml TaqRed polymerase
(Bioloine) and 2 ml crude genomic DNA extracts, filled up with
HPLC-grade H2O to a total volume of 25ml (for primer sequences
see Table VIII). PCR conditions were as follows: initial hotstart
denaturation at 941C for 3 min followed by 10 cycles with 941C for
30 s, 621C for 30 s with a 0.51C touchdown decline per cycle and
721C for 60 s, followed by 25 cycles with 941C for 30 s, 571C for 30 s
and 721C for 60 s, finished by a final elongation at 721C for 5 min.
The reaction was run on a DNA Engine Thermocycler (Bio-Rad).
After the reaction the PCR products were checked by standard gel
electrophoresis
Cell fractionation
Cell fractionation analysis for TERT binding to chromatin was
carried out as previously described, with minor modifications
(Tejera et al, 2010). Per sample one million cells were washed
once in cold PBS and then resuspended in 200ml ice-cold buffer
Aþ (10 mM HEPES pH 7.9, 10 mM KCl, 1.5 mM MgCl2, 0.34 M
sucrose, 10% glycerol, Complete Protease Inhibitor–EDTA (Roche)).
Samples were incubated for 5 min on ice and centrifuged for 5 min
at 1300 g and 41C. The supernatant was further cleaned by centri-
fugation for 25 min at 20 000 g and 41C, and represents the cyto-
plasmic fraction. The pellet was washed twice in 500ml buffer Aþ
and resuspended in 100 ml ice-cold buffer B (3 mM EDTA, 0.2 mM
EGTA, Complete Protease Inhibitor–EDTA (Roche)). Samples were
incubated for 30 min on ice and centrifuged for 5 min at 1700 g and
41C. The supernatant was further cleaned by centrifugation for
25 min at 20 000 g and 41C, and represents the nuclear soluble
fraction. The pellet was washed twice in 500ml buffer B, resus-
pended in 100 ml Laemmli buffer (Sigma Aldrich) and sonicated
twice for 10 min each in a water-bath sonicator. This sample
represents the chromatin fraction. The other fractions were equally
mixed with Laemmli buffer, and all samples were boiled at 951C for
5 min and separated on a 4–12% gradient gel (Novex, Invitrogen).
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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